InvestorsHub Logo
Followers 14
Posts 5842
Boards Moderated 0
Alias Born 04/24/2017

Re: None

Tuesday, 11/10/2020 11:16:24 AM

Tuesday, November 10, 2020 11:16:24 AM

Post# of 3504
The company's lead product candidates, CBLB502 showed radioprotective efficacy as a single therapy in non-human primates; and Protectan CBLB612 provided protection in a mouse model from lethal
hematopoietic-induced radiation sickness. $CBLI